Upadacitinib Impurity 91 | CAS 875781-41-2 - Request Quote
Upadacitinib Impurity 91
| SZ CAT No: | SZ-U005103 |
| CAS No | 875781-41-2 |
| Mol.F. | C9H12BrN3Si |
| Mol.Wt. | 270.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Upadacitinib Impurity 91 is chemically 5-Bromo-3-((trimethylsilyl)ethynyl)pyrazin-2-amine. Upadacitinib Impurity 91 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Impurity 91 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 875781-41-2
Purchase 875781-41-2
Order 875781-41-2
Enquire 875781-41-2
price of 875781-41-2
875781-41-2 Supplier
875781-41-2 Manufacturer
875781-41-2 Exporter
buy high quality Upadacitinib Impurity 91
Purchase Upadacitinib Impurity 91
Upadacitinib Impurity 91 suppliers
Upadacitinib Impurity 91 manufacturers
Upadacitinib Impurity 91 price
Order Upadacitinib Impurity 91
Enquire Upadacitinib Impurity 91
Upadacitinib Impurity 91 cost
Upadacitinib Impurity 91 Supplier
Upadacitinib Impurity 91 Distributor
Upadacitinib Impurity 91 for Method Validation
Upadacitinib Reference Standard
Upadacitinib Impurity 91 for ANDA Filing
Upadacitinib Impurity 91 for Forced Degradation Studies
Upadacitinib Impurity 91 Identification Standards
Upadacitinib Impurity 91 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.